Value of targeted testing for cytomegalovirus in preterm infants: 7 years’ experience at a tertiary London hospital
CMV causes a substantial disease burden in infants born <30 weeks gestation, whereby 6% have symptomatic CMV disease. We show the feasibility and value of targeted cCMV and opportunistic pCMV testing. In the absence of universal screening, targeted birth testing for cCMV in infants <30 weeks gestational age should be considered.
Authors
- Aaron Colin John Bell (ORCID: https://orcid.org/0009-0004-8321-1213)
- Elizabeth Whittaker (ORCID: https://orcid.org/0000-0002-7944-8793)
- Helen Payne (ORCID: https://orcid.org/0000-0002-7083-9384)
- Rebecca Faber (ORCID: https://orcid.org/0000-0002-5813-0823)
- Anjali Rampersad (ORCID: https://orcid.org/0000-0003-2699-7163)
- Paul Randell (ORCID: https://orcid.org/0000-0003-2988-2353)
- Hermione Lyall (ORCID: https://orcid.org/0000-0002-1255-1833)
- L. Tyszczuk (ORCID: https://orcid.org/0009-0006-7584-3709)
- R. Mistry (ORCID: https://orcid.org/0000-0002-1127-1979)
- Grace Li (ORCID: https://orcid.org/0000-0002-6661-0421)
- Ana Silva Ferreira (ORCID: https://orcid.org/0009-0001-6919-112X)
- H James (ORCID: https://orcid.org/0000-0002-7831-9463)
- Malaz Elsaddig (ORCID: https://orcid.org/0009-0002-1341-4758)
Institutions
- Imperial College Healthcare NHS Trust (GB)
- Stellenbosch University (ZA)
- Hillingdon Hospitals NHS Foundation Trust (GB)
- NIHR Imperial Biomedical Research Centre (GB)
- Imperial College London (GB)
Publication Details
- Journal
- Archives of Disease in Childhood Fetal & Neonatal
- Published
- 2025-12-03
- DOI
- https://doi.org/10.1136/archdischild-2025-329084
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00